Evaluation of Fibrosis in Liver Cirrhosis by Superparamagnetic Iron Oxide (SPIO)-Enhanced MR Imaging: Does the Radiological Non-Invasive Fibrosis Index Correlate with the Laboratory Non-Invasive Fibrosis Index?
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose : To evaluate the correlation between the radiological non-invasive hepatic fibrosis index (RNHFI), as determined by SPIO-enhanced MRI, and the laboratory non-invasive hepatic fibrosis index. Materials and Methods : Patients (99 total: 61 men and 38 women; mean age: 58 years) who underwent SPIO-enhanced MRI (1.5T) during 5 years included. These patients were subdivided into a liver cirrhosis group (LCG) and a non-liver cirrhosis group (non-LCG). Using PACS view, we measured the RNHFI (mean standard deviation of hepatic signal intensity (SD), noise-corrected coefficient of variation (CV)) of three ROIs in the liver parenchyma by SPIO-enhanced MRI. The laboratory non-invasive hepatic fibrosis index (AST-platelet ratio index (APRI)) of all patients was calculated from the laboratory data. We compared the RNHFI and APRI of LCG with those of non-LC group using Student’s t-test. A bivariate correlation was performed to investigate the relationship between the RNHFI and APRI in the LCG. Results : For the LCG, mean values of SD and CV by SPIO-enhanced MRI were 10.3±3.7 and 0.19±0.08, respectively. For the non-LCG, mean values of SD and CV were 6.5±1.6 and 0.08±0.05, respectively. The mean APRI of the LCG and the non-LCG were 2.04±1.7 and 0.32±0.32, respectively. The RNHFI and APRI were significantly different between both groups (p<0.05). For the LCG, the bivariate correlation between SD and APRI revealed a statistically significant positive correlation (r=0.5, p<0.001). In both groups, there was no statistically significant correlation between CV and APRI. Conclusion : A measurement of SD can be a simple and useful method for the evaluation of hepatic fibrosis.
Abstract
Purpose : To evaluate the correlation between the radiological non-invasive hepatic fibrosis index (RNHFI), as determined by SPIO-enhanced MRI, and the laboratory non-invasive hepatic fibrosis index. Materials and Methods : Patients (99 total: 61 men and 38 women; mean age: 58 years) who underwent SPIO-enhanced MRI (1.5T) during 5 years included. These patients were subdivided into a liver cirrhosis group (LCG) and a non-liver cirrhosis group (non-LCG). Using PACS view, we measured the RNHFI (mean standard deviation of hepatic signal intensity (SD), noise-corrected coefficient of variation (CV)) of three ROIs in the liver parenchyma by SPIO-enhanced MRI. The laboratory non-invasive hepatic fibrosis index (AST-platelet ratio index (APRI)) of all patients was calculated from the laboratory data. We compared the RNHFI and APRI of LCG with those of non-LC group using Student’s t-test. A bivariate correlation was performed to investigate the relationship between the RNHFI and APRI in the LCG. Results : For the LCG, mean values of SD and CV by SPIO-enhanced MRI were 10.3±3.7 and 0.19±0.08, respectively. For the non-LCG, mean values of SD and CV were 6.5±1.6 and 0.08±0.05, respectively. The mean APRI of the LCG and the non-LCG were 2.04±1.7 and 0.32±0.32, respectively. The RNHFI and APRI were significantly different between both groups (p<0.05). For the LCG, the bivariate correlation between SD and APRI revealed a statistically significant positive correlation (r=0.5, p<0.001). In both groups, there was no statistically significant correlation between CV and APRI. Conclusion : A measurement of SD can be a simple and useful method for the evaluation of hepatic fibrosis.
참고문헌 (20)
- Afdhal NH, "Evaluation of liver fibrosis: a concise review", Am J Gastroenterol, 99(6), pp.1160~1174 (2004)
- Talwalker JA, "Economic impact of hospitalization for endstage liver disease", Am J Gastroenterol, 97(6), pp.1562~ (2002)
- Thampanitchawong P, "World J Gastroenterol", 5(4), pp.301~304 (1999)
- Maharaj B, "Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver", Lancet, 1(8480), pp.523~525 (1986)
- Bedossa P, "Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C", Hepatology, 20(1 Pt 1), pp.15~20 (1994)
- Geroge J, "Biochemical markers of hepatic fibrogenesis: single measurements are not reliable enough to replace liver biopsy", J Gastroenterol Hepatol, 15(8), pp.819~821 (2000)
- McHutchison JG, "Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group", Gastroenterol Hepatol, 15(18), pp.945~951 (2000)
- Wai CT, "A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C", Hepatology, 38(2), pp.518~526 (2003)
- Sim SJ, "Efficacy of AST to platelet ratio index in predicting severe hepatic fibrosis and cirrhosis in chronic hepatitis B virus infection", Korean J Gastroenterol, (5), pp.340~347 (2005)
- Lucidarme O, "Noninvasive detection of liver fibrosis: is superparamagnetic iron oxide particle-enhanced MR imaging a contributive technique?", Eur Radiol, 13(3), pp.467~474 (2003)
- Tanimoto A, "Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell fuction", Radiology, 222(3), pp.661~666 (2002)
- Aguirre DA, "Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging", Radiology, 239(2), pp.425~437 (2006)
- Ito K, "Viral induced cirrhosis: grading of severity using MR imaging", AJR Am J Roentgenol, 173(3), pp.591~596 (1999)
- Aube C, "Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis", J Hepatol, 30(3), pp.472~478 (1999)
- Patel K, "Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C", J Gastroenterol Hepatol, 18(3), pp.253~257 (2003)
- Poon TC, "Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study", Clin Chem, 51(2), pp.328~335 (2005)
- Rockey DC, "Noninvasive measures of liver fibrosis", Hepatology, 43(2 suppl 1), pp.S113~S120 (2006)
- Castera L, "Prospective Comparison of Transient Elastography, Fibrotest, APRI, and Liver Biopsy for the Assessment of Fibrosis in Chronic Hepatitis C", Gastroenterology, 128(2), pp.343~350 (2005)
- "Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index", Radiology, 245(2), pp.458~466 (2007)
- Koinuma M, "Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis", J Magn Reson Imaging, 22(1), pp.80~85 (2005)